Navigation Links
Three Expert Opinion Journals now Publishing Original Research
Date:2/26/2008

LONDON, February 26 /PRNewswire/ -- Expert Opinion provides systematic and authoritative analysis enabling the pharmaceutical community to access and track key developments that lead to the creation of new drugs. Expert Opinion on Pharmacotherapy, Expert Opinion on Biological Therapy and Expert Opinion on Therapeutic Targets are now accepting original research.

Why publish with Expert Opinion

All the Expert Opinion journals publish independent and authoritative peer-reviewed articles; provide efficient and effective editorial support through from submission to publication that can take as little as 8 - 12 weeks. The journals are indexed by all major databases, including: Medline, Current Contents and EMBASE.

About the journals

Expert Opinion on Pharmacotherapy provides comprehensive coverage of emerging literature on newly approved compounds and assesses the likely impact of these new agents on existing pharmacotherapy of specific diseases. Expert Opinion on Pharmacotherapy focuses on new drugs and classes from development Phase III to those that have been available to pharmacopoeia for up to five years. Impact Factor: 1.733

Expert Opinion on Biological Therapy covers all aspects of biological therapy, from therapeutic peptides and proteins to gene transfer technologies and drug delivery systems, placing new advances in the context of current therapeutic practice and providing an expert opinion on the scope for future development. Impact Factor: 2.705

Expert Opinion on Therapeutic Targets publishes in-depth reports and reviews of the latest developments in the field of drug target discovery and validation. The journal provides an essential link between basic research on biological pathways and interactions and the development of the drugs for tomorrow. It is distinguished from other publications by its high-quality authorship and expertly drafted articles, structured to incorporate the author's expertise on the subject. Impact Factor: 2.662

For more information, please contact:

Elizabeth Knowles

email: elizabeth.knowles@informa.com

Tel no: +44(0)20-7017-4742


'/>"/>
SOURCE Expert Opinion
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. KGI Elects Three New Members to Board of Trustees
2. Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer
3. Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Societys 29th Annual Meeting
4. Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents
5. European Union has Three-Speed Healthcare System - Many Countries Lagging in Reform
6. Three PDX (Pralatrexate) Studies Presented at the 2007 AACR-NCI-EORTC Conference
7. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
8. Pharmasset to Present at Three Investor Conferences in November 2007
9. Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences
10. Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge
11. Gen-Probe to Webcast Three Upcoming Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... pharmaceutical and biotechnology industries to improve patient outcomes and quality of life, will ... analytical testing are being attributed to new regulatory requirements for all new drug ...
(Date:10/11/2017)... CA, USA (PRWEB) , ... October 11, 2017 , ... ... to take place on 7th and 8th June 2018 in San Francisco, CA. The ... influencers as well as several distinguished CEOs, board directors and government officials from around ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... the implantation and pregnancy rates in frozen and fresh in vitro fertilization ... progesterone and maternal age to IVF success. , After comparing the results from ...
(Date:10/10/2017)... ... 2017 , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on ... DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of ...
Breaking Biology Technology:
(Date:3/30/2017)... Trends, opportunities and forecast in this market ... (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, vein ... use industry (government and law enforcement, commercial and retail, ... others), and by region ( North America ... Pacific , and the Rest of the World) ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by ... Global Forecast to 2022", published by MarketsandMarkets, the market is expected to be ... 2017 and 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):